BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31845585)

  • 41. Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination.
    Milagre I; Nunes MJ; Moutinho M; Rivera I; Fuso A; Scarpa S; Gama MJ; Rodrigues E
    J Alzheimers Dis; 2010; 22(4):1209-21. PubMed ID: 20930312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Upregulation of cholesterol 24-hydroxylase following hypoxia-ischemia in neonatal mouse brain.
    Lu F; Zhu J; Guo S; Wong BJ; Chehab FF; Ferriero DM; Jiang X
    Pediatr Res; 2018 Jun; 83(6):1218-1227. PubMed ID: 29718007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population.
    Ma SL; Tang NL; Lam LC; Chiu HF
    Int Psychogeriatr; 2006 Mar; 18(1):37-45. PubMed ID: 16734927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CYP46A1-mediated cholesterol turnover induces sex-specific changes in cognition and counteracts memory loss in ovariectomized mice.
    Latorre-Leal M; Rodriguez-Rodriguez P; Franchini L; Nikolidakis O; Daniilidou M; Delac L; Varshney MK; Arroyo-García LE; Eroli F; Winblad B; Blennow K; Zetterberg H; Kivipelto M; Pacciarini M; Wang Y; Griffiths WJ; Björkhem I; Matton A; Nalvarte I; Merino-Serrais P; Cedazo-Minguez A; Maioli S
    Sci Adv; 2024 Jan; 10(4):eadj1354. PubMed ID: 38266095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and pharmacokinetic study of a
    Chen Z; Chen J; Mast N; Rong J; Deng X; Shao T; Fu H; Yu Q; Sun J; Shao Y; Josephson L; Collier TL; Pikuleva I; Liang SH
    Bioorg Med Chem Lett; 2020 May; 30(9):127068. PubMed ID: 32178974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism.
    Kölsch H; Lütjohann D; Jessen F; Popp J; Hentschel F; Kelemen P; Schmitz S; Maier W; Heun R
    Eur Psychiatry; 2009 Apr; 24(3):183-90. PubMed ID: 19286353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of Soticlestat, a Potent and Selective Inhibitor for Cholesterol 24-Hydroxylase (CH24H).
    Koike T; Yoshikawa M; Ando HK; Farnaby W; Nishi T; Watanabe E; Yano J; Miyamoto M; Kondo S; Ishii T; Kuroita T
    J Med Chem; 2021 Aug; 64(16):12228-12244. PubMed ID: 34387987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cholesterol-24-hydroxylase (CYP46) in the old brain: Analysis of positive populations and factors triggering its expression in astrocytes.
    Cataldi GG; Elorza SD; Toledano-Zaragoza A; de Olmos S; Cragnolini AB; Martín MG
    J Comp Neurol; 2023 Feb; 531(3):486-499. PubMed ID: 36453552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of Glycyrrhiza Polysaccharide on Human Cytochrome P450 46A1 in vitro and in vivo: Implications in Treating Neurological Diseases.
    Du J; Chen Z; Chen X; Zhang J; Wang Y; Zhao T; Wang D; Wang C; Chen Y; Meng Q; Sun H; Liu K; Wu J
    Curr Drug Metab; 2024 May; ():. PubMed ID: 38797896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CYP46A1 and the APOEε4 Allele Polymorphisms Correlate with the Risk of Alzheimer's Disease.
    Li L; Zeng F; Liu YH; Li HY; Dong SY; Peng ZY; Wang YJ; Zhou HD
    Mol Neurobiol; 2018 Oct; 55(10):8179-8187. PubMed ID: 29516283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Marked change in the balance between CYP27A1 and CYP46A1 mediated elimination of cholesterol during differentiation of human neuronal cells.
    Milagre I; Olin M; Nunes MJ; Moutinho M; Lövgren-Sandblom A; Gama MJ; Björkhem I; Rodrigues E
    Neurochem Int; 2012 Jan; 60(2):192-8. PubMed ID: 22185844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cholesterol-metabolizing cytochromes P450.
    Pikuleva IA
    Drug Metab Dispos; 2006 Apr; 34(4):513-20. PubMed ID: 16434543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased Levels of 27-Hydroxycholesterol Induced by Dietary Cholesterol in Brain Contribute to Learning and Memory Impairment in Rats.
    Zhang X; Lv C; An Y; Liu Q; Rong H; Tao L; Wang Y; Wang Y; Xiao R
    Mol Nutr Food Res; 2018 Feb; 62(3):. PubMed ID: 29193679
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NPC1 enables cholesterol mobilization during long-term potentiation that can be restored in Niemann-Pick disease type C by CYP46A1 activation.
    Mitroi DN; Pereyra-Gómez G; Soto-Huelin B; Senovilla F; Kobayashi T; Esteban JA; Ledesma MD
    EMBO Rep; 2019 Nov; 20(11):e48143. PubMed ID: 31535451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions with Efavirenz Involving Simultaneous Inducing and Inhibitory Effects on Cytochromes.
    Marzolini C; Rajoli R; Battegay M; Elzi L; Back D; Siccardi M
    Clin Pharmacokinet; 2017 Apr; 56(4):409-420. PubMed ID: 27599706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 24S-hydroxycholesterol and cholesterol-24S-hydroxylase (CYP46A1) in the retina: from cholesterol homeostasis to pathophysiology of glaucoma.
    Fourgeux C; Bron A; Acar N; Creuzot-Garcher C; Bretillon L
    Chem Phys Lipids; 2011 Sep; 164(6):496-9. PubMed ID: 21531213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease.
    Kacher R; Lamazière A; Heck N; Kappes V; Mounier C; Despres G; Dembitskaya Y; Perrin E; Christaller W; Sasidharan Nair S; Messent V; Cartier N; Vanhoutte P; Venance L; Saudou F; Néri C; Caboche J; Betuing S
    Brain; 2019 Aug; 142(8):2432-2450. PubMed ID: 31286142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain.
    Mast N; Norcross R; Andersson U; Shou M; Nakayama K; Bjorkhem I; Pikuleva IA
    Biochemistry; 2003 Dec; 42(48):14284-92. PubMed ID: 14640697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo consequences of cholesterol-24S-hydroxylase (CYP46A1) inhibition by voriconazole on cholesterol homeostasis and function in the rat retina.
    Fourgeux C; Martine L; Acar N; Bron AM; Creuzot-Garcher CP; Bretillon L
    Biochem Biophys Res Commun; 2014 Apr; 446(3):775-81. PubMed ID: 24491555
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuronal cholesterol metabolism increases dendritic outgrowth and synaptic markers via a concerted action of GGTase-I and Trk.
    Moutinho M; Nunes MJ; Correia JC; Gama MJ; Castro-Caldas M; Cedazo-Minguez A; Rodrigues CM; Björkhem I; Ruas JL; Rodrigues E
    Sci Rep; 2016 Aug; 6():30928. PubMed ID: 27491694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.